TAK-004
- Generic Name
- TAK-004
A First-In-Human Study of TAK-004 in Healthy Adults
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 240
- Registration Number
- NCT06236009
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath